Concepedia

Cesare Mondadori

CM

41

Publications

2.1K

Citations

27

H-Index

1974

Active since

Affiliations

Novartis (Switzerland)(Current)

University of Zurich

University of Oxford

Cesare Mondadori is an author at Novartis (Switzerland) specializing in social sciences, neuroscience, and neuropharmacology.

Top concepts

Publications per year

1974–2011

41

Publications

41

CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.

John Lehmann, A. Hutchison, Stephen E. McPherson et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 226 citations

SGS742: the first GABAB receptor antagonist in clinical trials

Wolfgang Froestl, Michela Gallagher, Helen Jenkins et al. · Biochemical Pharmacology · 2004 · 187 citations

, , +3

NMDA receptor antagonists can enhance or impair learning performance in animals

Cesare Mondadori, Lawrence Weiskrantz, H. Buerki et al. · Experimental Brain Research · 1989 · 183 citations

, , +11

Phosphorylation and destabilization of human period I clock protein by human casein kinase Iε

George A. Keesler, Fernando Camacho, Yong Guo et al. · Neuroreport · 2000 · 136 citations

CGP 36742: The first orally active GABAB blocker improves the cognitive performance of mice, rats, and rhesus monkeys

Cesare Mondadori, Joachim Jaekel, G. Preiswerk · Behavioral and Neural Biology · 1993 · 120 citations

, , +12

Rows per page

1–5 of 41